Skip to content
drillr.ai
Sign up

605016.SH

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

SSE · Consumer Defensive · Packaged Foods · CN

CNY 17.60
+0.11%
Ask drillr

  • Oct 29, 2026, 08:39 UTC

    Bailong Chuangyuan reported third-quarter 2026 revenue of 374 million yuan, up 16.87% year over year, and nine-month revenue of 1.133 billion yuan, up 16.95%.

    Source:

  • Oct 12, 2026, 08:51 UTC

    China Securities Regulatory Commission approved registration of Bailong Chuangyuan’s proposed convertible bond issuance to unspecified investors.

    Source:

  • Sep 22, 2026, 12:19 UTC

    Bailong Chuangyuan's board approved extending the validity of the shareholder resolution for its convertible corporate bond issuance by another twelve months, to October 10, 2027, with all other terms unchanged.

    Source:

  • Sep 9, 2026, 08:01 UTC

    Bailong Chuangyuan announced it invested 10 million RMB of its own funds to establish a wholly-owned subsidiary in Kunming, Bailong Chuangyuan (Kunming) Biotechnology Co., Ltd., with registered capital of 10 million RMB and 100% ownership.

    Source:

  • Aug 30, 2026, 08:36 UTC

    Bailong Chuangyuan announced a cash dividend of 0.75 yuan per 10 shares (tax inclusive) for the first half of 2026.

    Source:

  • Jul 23, 2026, 07:34 UTC

    Bailongchuangyuan's controlling shareholder's concerted actor Dou Guangpeng partially released a pledge of 1.1 million shares and extended the pledge of 5.9 million shares to CITIC Securities.

    Source: